Navigation Links
FDA approves HeartMate II mechanical heart pump for heart-failure patients
Date:5/2/2008

NEW YORK (April 25, 2008) -- Heart failure patients at NewYork-Presbyterian Hospital/Columbia University Medical Center were among the first to be implanted with the HeartMate II LVAS (Left Ventricular Assist System) -- a miniature mechanical pump that helps weak hearts pump blood -- that has now received approval by the FDA as of April 21 for broad use as bridge to transplantation. As part of clinical trials leading to approval, 22 patients received the new device at NewYork-Presbyterian/Columbia -- more than any other hospital in the New York area.

Clinical research studies at medical centers, including NewYork-Presbyterian/Columbia, showed the HeartMate II to be safe and effective, with improved quality of life and survival compared with historical norms for heart-failure patients. In addition, the device is designed to be quieter and more durable than other FDA approved devices.

One-eighth the size of the original HeartMate LVAS, the HeartMate II provides continuous blood flow through the circulatory system using only one moving part -- a rotary pumping mechanism.

"For patients whose hearts are unable to effectively pump blood due to severe heart failure, this remarkable device can help them have active lives as they await a heart transplant," says Dr. Yoshifumi Naka, principal investigator of the clinical research studies and director of cardiac transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center and associate professor of surgery at Columbia University College of Physicians and Surgeons.

With around 2,200 donor hearts available annually, there are large numbers of patients with end-stage heart failure placed on heart transplant waiting lists. These patients would be candidates to receive the HeartMate II LVAS as a therapeutic option to sustain them until transplant.

FDA approval was based on one-year follow-up data from the first 194 HeartMate II patients enrolled in the trial
'/>"/>

Contact: Belinda Mager
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
2. FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis
3. FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults
4. FDA APPROVES ROTARIX(R) [Rotavirus Vaccine, live, oral], THE FIRST VACCINE LICENSED TO COMPLETE THE ROTAVIRUS IMMUNIZATION SERIES BY FOUR MONTHS OF AGE
5. House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
6. VeriPrime Approves New Best Practices for Beef Production
7. U.S. EPA Approves Registration of Antimicrobial Copper Alloys
8. Arizona Senate Approves Smoking Cessation Treatments for State Medicaid Beneficiaries
9. CMS Approves Home Sleep Testing for Diagnosis of OSA; AASM Experts Available for Comment
10. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
11. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... Saving Moses, a global humanitarian organization ... traveling to Angola, Africa March 7-14 to visit malnutrition ... , This will be the organizations fifth time to ... commitment to the region’s population by saving infants and ... with the mothers and babies of the malnutrition program, ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... also known as the pharmacokinetics of a drug refers ... a pharmaceutical compound inside an organism. When toxicity studies ... ADME-Tox or ADMET or ADME/Tox. Increasing focus on lowering ... adoption of ADME-toxicology testing worldwide. The traditional drug development ...
(Date:3/6/2015)... 06, 2015 “On Tap” takes the audience ... grand stage, to the silver screen and to modern day ... toe-tapping numbers and their famous eye-high kicks! Producers, directors and ... history of tap dancing in this robust show, showcasing one ... the United States. , “On Tap” is proud to ...
(Date:3/6/2015)... 06, 2015 At Natural Products ... today the launch of its powerful, location-aware iOS ... and sustainable products at any retailer that carries ... at Expo West Booth 6054. , Makeena’s ... Kosher, non-GMO, organic, Paleo, and vegan, among many ...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3
... NEW BRUNSWICK, N.J. , March 15 ... female-specific AIDS service organization, has launched "I Stand With NJWAN", ... families, individuals, corporations, social service agencies, and the faith-based community ... women in NJ. At 35%, New Jersey has ...
... VEGAS , March 15 Each year, nearly three million ... drug addiction, prostitution, disease and mental illness.  In honor of National Safe ... Boxed In: Text-4-Help: 69866" campaign to raise awareness of the risks associated ... and across the country to youth in crisis.   , ...
... , March 15 /PRNewswire-FirstCall/ - The Westaim ... RiskMetrics Group (formerly Institutional Shareholder Services or "ISS") is ... the financing resolution to be submitted to shareholders of ... March 25, 2010 (the Financing Resolution). The ...
... 2010)Patient selection is key for vertebroplastya minimally invasive ... painful osteoporotic vertebral compression fractures that fail to ... successful, according to a study of more than ... Additionally, collaboration between an interventional radiologist and other ...
... Soulen, M.D., FSIR, delivered the 2010 Dr. Charles ... Radiology,s 35th Annual Scientific Meeting in Tampa, Fla. ... an interventional radiologist,s extraordinary contributions to the field, ... in interventional radiology. Soulen, who addressed "IR: ...
... around the heart, can provide extra information compared with standard ... research by cardiologists at Emory University School of Medicine. The ... be measured by X-ray imaging techniques such as CT or ... keeper, in that it could help a cardiologist decide whether ...
Cached Medicine News:Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 2Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 2Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 4Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 5Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 6Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 7Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 8Health News:Westaim Announces Recommendation from RiskMetrics Group 2Health News:Westaim Announces Recommendation from RiskMetrics Group 3Health News:Westaim Announces Recommendation from RiskMetrics Group 4Health News:Westaim Announces Recommendation from RiskMetrics Group 5Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 2Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 3Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 2Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 3Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 4Health News:Imaging fat layer around heart can help predict disease 2
(Date:3/6/2015)... 6, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... $9 million milestone payment from Biogen Idec related to ... Rx in infants with spinal muscular atrophy (SMA).  ... ISIS-SMN Rx, is a randomized, double-blind, sham-procedure controlled ... SMA.  The study will evaluate the efficacy and safety ...
(Date:3/5/2015)... --  MeridianRx earned highest possible score of ... indicators during its recent URAC accreditation review for ... proud of earning this level of accreditation from ... Officer of MeridianRx. "It is a testament to ... and innovation." URAC,s leading indicators are ...
(Date:3/5/2015)... DIEGO , March 5, 2015  Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its fourth quarter and full year ... March 16, 2015, before the market opens for ... will host a conference call to discuss the ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5MeridianRx Earns Highest URAC Accreditation Status 2Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2
... KONG, Oct. 11 OrbusNeich today reported the completion ... its Genous Bio-engineered R stent at 11 sites in ... patient, controlled study is to demonstrate the safety and ... the Medtronic Endeavor® Sprint stent in patients with symptoms ...
... BioStorage Technologies, a global leader in sample management, ... pharmaceutical and biotechnology industries, has expanded its sample ... including sample aliquoting and nucleic acid extraction and ... sample management continues to grow, BioStorage Technologies has ...
Cached Medicine Technology:Randomized Clinical Trial of OrbusNeich's Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment 2Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services 2
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting...
Inquire...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
... viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry ... 100-1000 ... 1.0~1.5 Imprecision(%) ... 10 Dimensions: ...
Medicine Products: